A total of >90% of the analyzed tumor entities had at least one STING positive case, >65% tumor entities had at least one case with strong STING positivity, >50% of all tumors were STING-positive, and 18% of all tumors were strongly STING-positive, demonstrating that STING expression is a common feature of cancer cells. This evidence concerns the gene STING1 and cancer.